Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| ACHILLION PHARMACEUTICALS INC | 8 402 014 | déclaré | 26 sept. 2014 | tx 55+10 598 946−6 799 560 |
| Wave Life Sciences Ltd. | 7 775 207 | déclaré | 24 janv. 2019 | tx 3+686 556 |
| Ra Pharmaceuticals, Inc. | 4 858 260 | déclaré | 12 déc. 2018 | tx 1+1 006 452 |
| KALA BIO, Inc. | 4 537 478 | déclaré | 03 oct. 2018 | tx 1+2 424 242 |
| Aclaris Therapeutics, Inc. | 2 125 769 | déclaré | 16 sept. 2016 | tx 5−525 550 |
| DERMA SCIENCES, INC. | 1 994 876 | déclaré | 29 avr. 2013 | tx 1+3 945 |
| ARVINAS, INC. | 1 847 002 | déclaré | 01 oct. 2018 | tx 5+3 138 412−6 949 846 |
| KalVista Pharmaceuticals, Inc. | 1 441 070 | déclaré | 12 oct. 2017 | tx 1+850 000 |
| ARADIGM CORP | 1 081 410 | déclaré | 29 oct. 2008 | tx 1−5 600 000 |
| BIOSPECIFICS TECHNOLOGIES CORP | 658 770 | déclaré | 17 févr. 2010 | tx 31+44 586−182 833 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 24 janv. 2019 | PURCHASE | Wave Life Sciences Ltd. | 263 158 | 38.00 USD | |
| 12 déc. 2018 | PURCHASE | Ra Pharmaceuticals, Inc. | 1 006 452 | 15.50 USD | |
| 03 oct. 2018 | PURCHASE | KALA BIO, Inc. | 2 424 242 | 8.25 USD | |
| 01 oct. 2018 | PURCHASE | ARVINAS, INC. | 1 000 000 | 16.00 USD | |
| 01 oct. 2018 | CONVERSION | ARVINAS, INC. | 291 410 | — | |
| 01 oct. 2018 | CONVERSION | ARVINAS, INC. | 1 847 002 | — | |
| 01 oct. 2018 | CONVERSION | ARVINAS, INC. | 6 002 761 | — | deriv |
| 01 oct. 2018 | CONVERSION | ARVINAS, INC. | 947 085 | — | deriv |
| 18 déc. 2017 | EXERCISE | Dicerna Pharmaceuticals Inc | 2 645 442 | — | |
| 18 déc. 2017 | EXERCISE | Dicerna Pharmaceuticals Inc | 76 500 | 3.19 USD | deriv |
| 13 nov. 2017 | PURCHASE | Wave Life Sciences Ltd. | 400 000 | 23.30 USD | |
| 14 nov. 2017 | PURCHASE | Wave Life Sciences Ltd. | 23 398 | 24.00 USD | |
| 12 oct. 2017 | PURCHASE | KalVista Pharmaceuticals, Inc. | 850 000 | 8.50 USD | 1er après silence |
| 15 sept. 2016 | SALE | Aclaris Therapeutics, Inc. | 20 000 | 24.04 USD | |
| 15 sept. 2016 | SALE | Aclaris Therapeutics, Inc. | 273 000 | 24.00 USD | |
| 15 sept. 2016 | SALE | Aclaris Therapeutics, Inc. | 58 950 | 24.20 USD | |
| 16 sept. 2016 | SALE | Aclaris Therapeutics, Inc. | 150 000 | 24.50 USD | |
| 16 sept. 2016 | SALE | Aclaris Therapeutics, Inc. | 23 600 | 24.54 USD | |
| 24 sept. 2014 | SALE | ACHILLION PHARMACEUTICALS INC | 175 720 | 11.24 USD | |
| 24 sept. 2014 | SALE | ACHILLION PHARMACEUTICALS INC | 319 100 | 11.25 USD | |
| 24 sept. 2014 | SALE | ACHILLION PHARMACEUTICALS INC | 210 109 | 11.29 USD | |
| 24 sept. 2014 | SALE | ACHILLION PHARMACEUTICALS INC | 500 000 | 11.28 USD | |
| 25 sept. 2014 | SALE | ACHILLION PHARMACEUTICALS INC | 116 186 | 11.01 USD | |
| 25 sept. 2014 | SALE | ACHILLION PHARMACEUTICALS INC | 131 800 | 11.06 USD | |
| 25 sept. 2014 | SALE | ACHILLION PHARMACEUTICALS INC | 250 000 | 11.06 USD |
2 achats déclarés après au moins 12 mois de silence — dernière occurrence le 12 oct. 2017.